JP2022505471A5 - - Google Patents
Info
- Publication number
- JP2022505471A5 JP2022505471A5 JP2021521516A JP2021521516A JP2022505471A5 JP 2022505471 A5 JP2022505471 A5 JP 2022505471A5 JP 2021521516 A JP2021521516 A JP 2021521516A JP 2021521516 A JP2021521516 A JP 2021521516A JP 2022505471 A5 JP2022505471 A5 JP 2022505471A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- independently
- substituted
- formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862748517P | 2018-10-21 | 2018-10-21 | |
| US62/748,517 | 2018-10-21 | ||
| PCT/US2019/057260 WO2020086481A1 (en) | 2018-10-21 | 2019-10-21 | Novel uses |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505471A JP2022505471A (ja) | 2022-01-14 |
| JP2022505471A5 true JP2022505471A5 (enExample) | 2022-10-28 |
| JP7480135B2 JP7480135B2 (ja) | 2024-05-09 |
Family
ID=70331921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021521516A Active JP7480135B2 (ja) | 2018-10-21 | 2019-10-21 | 新規使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12194042B2 (enExample) |
| EP (1) | EP3866808A4 (enExample) |
| JP (1) | JP7480135B2 (enExample) |
| KR (1) | KR20210080418A (enExample) |
| CN (1) | CN113194955A (enExample) |
| AU (1) | AU2019364274C1 (enExample) |
| BR (1) | BR112021007571A2 (enExample) |
| CA (1) | CA3117148A1 (enExample) |
| IL (1) | IL282396A (enExample) |
| MX (1) | MX2021004531A (enExample) |
| WO (1) | WO2020086481A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220184240A1 (en) * | 2019-04-12 | 2022-06-16 | Intra-Cellular Therapies, Inc. | Organic compounds |
| US12410175B2 (en) | 2019-09-03 | 2025-09-09 | Intra-Cellular Therapies, Inc. | Compounds |
| EP4284806A4 (en) * | 2021-01-27 | 2025-02-26 | Intra-Cellular Therapies, Inc. | Salt crystals |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1585771A (zh) * | 2001-11-09 | 2005-02-23 | 先灵公司 | 多环鸟嘌呤衍生物磷酸二酯酶v抑制剂 |
| PT2152712E (pt) | 2007-05-11 | 2012-02-29 | Pfizer | Compostos amino-heterocíclicos |
| EP2939676A1 (en) * | 2007-12-06 | 2015-11-04 | Intra-Cellular Therapies, Inc. | Organic compounds |
| WO2010098839A1 (en) | 2009-02-25 | 2010-09-02 | Intra-Cellular Therapies, Inc. | Pde 1 inhibitors for ophthalmic disorders |
| TW201206937A (en) * | 2010-05-31 | 2012-02-16 | Intra Cellular Therapies Inc | Organic compounds |
| CA2961212C (en) | 2014-09-17 | 2024-02-06 | Intra-Cellular Therapies, Inc. | Compounds and methods |
| EP4112053B1 (en) | 2016-10-11 | 2024-02-14 | Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) | Treatment of synucleinopathies |
-
2019
- 2019-10-21 WO PCT/US2019/057260 patent/WO2020086481A1/en not_active Ceased
- 2019-10-21 US US17/287,478 patent/US12194042B2/en active Active
- 2019-10-21 CN CN201980084405.9A patent/CN113194955A/zh active Pending
- 2019-10-21 MX MX2021004531A patent/MX2021004531A/es unknown
- 2019-10-21 EP EP19877180.0A patent/EP3866808A4/en active Pending
- 2019-10-21 KR KR1020217013853A patent/KR20210080418A/ko not_active Ceased
- 2019-10-21 JP JP2021521516A patent/JP7480135B2/ja active Active
- 2019-10-21 AU AU2019364274A patent/AU2019364274C1/en active Active
- 2019-10-21 BR BR112021007571-2A patent/BR112021007571A2/pt unknown
- 2019-10-21 CA CA3117148A patent/CA3117148A1/en active Pending
-
2021
- 2021-04-18 IL IL282396A patent/IL282396A/en unknown
-
2024
- 2024-12-03 US US18/967,095 patent/US20250090536A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2317817C2 (ru) | Применение (1s,2r) энантиомера милнаципрана для получения лекарственного средства | |
| RU2485943C2 (ru) | Бупропиона гидробромид и его терапевтические применения | |
| AU2005218047B2 (en) | Derivatives of venlafaxine and methods of preparing and using the same | |
| TWI335217B (en) | Pharmaceutical formulations of modafinil | |
| JP2025509088A5 (enExample) | ||
| US8729120B2 (en) | Adjunctive therapy for depression | |
| RU2006141416A (ru) | Пролекарства леводопа, композиции на их основе и их применения | |
| EP1641461B1 (fr) | Association d'un antagoniste ou agoniste inverse du recepteur h3 de l'histamine avec un anti-psychotique ou un antidepresseur et son utilisation pour preparer un medicament prevenant des effets indesirables de medicaments psychotropes | |
| TW200808696A (en) | Alpha-aminoamide derivatives useful in the treatment of cognitive disorders | |
| Sanford et al. | Rotigotine transdermal patch: a review of its use in the treatment of Parkinson’s disease | |
| RU2006107534A (ru) | Комбинация, включающая альфа-2-дельта-лиганд анд и ssri и/или snri, для лечения депрессии и тревожного расстройства | |
| MX2008000249A (es) | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. | |
| US12194042B2 (en) | Uses | |
| JP2006505548A (ja) | Ｐｐａｒリガンドと抗酸化剤の会合および肥満の治療のためのその使用 | |
| RU2021114144A (ru) | Новые применения | |
| TW201412304A (zh) | 瑞沙吉林之非經腸調配物 | |
| JP2021529826A (ja) | ブプロピオンを用いてテトラベナジン代謝物の血漿濃度を調節する方法 | |
| JP2012184263A (ja) | 脳梗塞に関連する脳血管障害の治療に有用なピラゾロン化合物 | |
| JP2002511408A (ja) | 神経疾患のための新しい治療 | |
| JP2012240935A (ja) | パーキンソン病の体幹症状（姿勢反射異常）の治療剤 | |
| AU2006209368B2 (en) | New association between agomelatine and a noradrenaline reuptake inhibitor and pharmaceutical compositions containing it | |
| AU2006293671B2 (en) | 2-aminoalcohols for the treatment of neurodegenerative diseases | |
| US20260097017A1 (en) | Tasipimidine and cyp2d6 inhibitor combination treatment | |
| Behere et al. | Antidepressants | |
| Suvar | Antidepressants |